Krzysztof Gołąb Selected Research

ovocystatin

4/2022	Ovocystatin Induced Changes in Expression of Alzheimer's Disease Relevant Proteins in APP/PS1 Transgenic Mice.
3/2019	Beneficial effect of ovocystatin on the cognitive decline in APP/PS1 transgenic mice.
1/2014	Ovocystatin affects actin cytoskeleton organization and induces proapoptotic activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Krzysztof Gołąb Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 01/2014
2	Cognitive Dysfunction 04/2022 - 03/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 03/2019
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2015
1	Alzheimer Disease (Alzheimer's Disease) 04/2022
1	Cicatrix (Scar) 07/2021
1	Wounds and Injuries (Trauma) 07/2021
1	Dementia (Dementias) 03/2019
1	Hypercholesterolemia 07/2015
1	Atherosclerosis 07/2015
1	Melanoma (Melanoma, Malignant) 01/2014

Drug/Important Bio-Agent (IBA)

3	ovocystatinIBA 04/2022 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 07/2015
2	Cystatin CIBA 04/2022 - 03/2019
2	Cysteine (L-Cysteine)FDA Link 01/2021 - 01/2015
1	Biological ProductsIBA 04/2022
1	Local Anti-Infective Agents (Antiseptics)IBA 07/2021
1	Collagen Type III (Type III Collagen)IBA 07/2021
1	egg-white cystatinIBA 01/2021
1	Cathepsin BIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Amyloid (Amyloid Fibrils)IBA 03/2019
1	Cysteine Proteases (Cysteine Protease)IBA 03/2019
1	Complement System Proteins (Complement)IBA 01/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2015